OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) results in sustained lowering of body weight in most patients, but the mechanisms involved are poorly understood. The aim of this study was to obtain support for the notion that reprogramming of defended body weight, rather than passive restriction of energy intake, is a fundamental mechanism of RYGB. METHODS: Male C57BL6J mice reaching different degrees of obesity on a high-fat diet either with ad libitum access or with caloric restriction (weight-reduced) were subjected to RYGB. RESULTS: RYGB-induced weight loss and fat mass loss were proportional to pre-surgical levels, with moderately obese mice losing less body weight and fat compared with very obese mice. Remarkably, mice that were weight-reduced to the level of chow controls before surgery immediately gained weight after surgery, exclusively accounted for by lean mass gain. CONCLUSIONS: The results provide additional evidence for reprogramming of a new defended body weight as an important principle by which RYGB lastingly suppresses body weight. RYGB appears to selectively abolish defense of a higher fat mass level, while remaining sensitive to the defense of lean mass. The molecular and physiological mechanisms underlying this reprogramming remain to be elucidated.
OBJECTIVE: Roux-en-Y gastric bypass surgery (RYGB) results in sustained lowering of body weight in most patients, but the mechanisms involved are poorly understood. The aim of this study was to obtain support for the notion that reprogramming of defended body weight, rather than passive restriction of energy intake, is a fundamental mechanism of RYGB. METHODS: Male C57BL6J mice reaching different degrees of obesity on a high-fat diet either with ad libitum access or with caloric restriction (weight-reduced) were subjected to RYGB. RESULTS: RYGB-induced weight loss and fat mass loss were proportional to pre-surgical levels, with moderately obesemice losing less body weight and fat compared with very obesemice. Remarkably, mice that were weight-reduced to the level of chow controls before surgery immediately gained weight after surgery, exclusively accounted for by lean mass gain. CONCLUSIONS: The results provide additional evidence for reprogramming of a new defended body weight as an important principle by which RYGB lastingly suppresses body weight. RYGB appears to selectively abolish defense of a higher fat mass level, while remaining sensitive to the defense of lean mass. The molecular and physiological mechanisms underlying this reprogramming remain to be elucidated.
Authors: John E Blundell; Phillipa Caudwell; Catherine Gibbons; Mark Hopkins; Erik Näslund; Neil A King; Graham Finlayson Journal: Br J Nutr Date: 2011-07-07 Impact factor: 3.718
Authors: Ida J Hatoum; Nicholas Stylopoulos; Amanda M Vanhoose; Kelli L Boyd; Deng Ping Yin; Kate L J Ellacott; Lian Li Ma; Kasia Blaszczyk; Julia M Keogh; Roger D Cone; I Sadaf Farooqi; Lee M Kaplan Journal: J Clin Endocrinol Metab Date: 2012-04-06 Impact factor: 5.958
Authors: Christopher M Weise; Pradeep Thiyyagura; Eric M Reiman; Kewei Chen; Jonathan Krakoff Journal: Hum Brain Mapp Date: 2015-03-13 Impact factor: 5.038
Authors: Jianping Ye; Zheng Hao; Michael B Mumphrey; R Leigh Townsend; Laurel M Patterson; Nicholas Stylopoulos; Heike Münzberg; Christopher D Morrison; Daniel J Drucker; Hans-Rudolf Berthoud Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-01-15 Impact factor: 3.619
Authors: Samantha Scholtz; Alexander D Miras; Navpreet Chhina; Christina G Prechtl; Michelle L Sleeth; Norlida M Daud; Nurhafzan A Ismail; Giuliana Durighel; Ahmed R Ahmed; Torsten Olbers; Royce P Vincent; Jamshid Alaghband-Zadeh; Mohammad A Ghatei; Adam D Waldman; Gary S Frost; Jimmy D Bell; Carel W le Roux; Anthony P Goldstone Journal: Gut Date: 2013-08-20 Impact factor: 31.793
Authors: Erin Fothergill; Juen Guo; Lilian Howard; Jennifer C Kerns; Nicolas D Knuth; Robert Brychta; Kong Y Chen; Monica C Skarulis; Mary Walter; Peter J Walter; Kevin D Hall Journal: Obesity (Silver Spring) Date: 2016-05-02 Impact factor: 5.002
Authors: Michael W Schwartz; Randy J Seeley; Lori M Zeltser; Adam Drewnowski; Eric Ravussin; Leanne M Redman; Rudolph L Leibel Journal: Endocr Rev Date: 2017-08-01 Impact factor: 19.871
Authors: Mohammed K Hankir; Marianne Patt; Jörg T W Patt; Georg A Becker; Michael Rullmann; Mathias Kranz; Winnie Deuther-Conrad; Kristin Schischke; Florian Seyfried; Peter Brust; Swen Hesse; Osama Sabri; Ute Krügel; Wiebke K Fenske Journal: Front Neurosci Date: 2017-01-13 Impact factor: 4.677
Authors: Kavaljit H Chhabra; Jessica M Adams; Graham L Jones; Miho Yamashita; Martin Schlapschy; Arne Skerra; Marcelo Rubinstein; Malcolm J Low Journal: Mol Metab Date: 2016-08-05 Impact factor: 7.422